Osteosarcoma

被引:283
作者
Meyers, PA
Gorlick, R
机构
[1] Department of Pediatrics, Memorial Sloan-Kettering Can. Ctr., New York, NY 10021
关键词
D O I
10.1016/S0031-3955(05)70540-X
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Over the last several decades, significant advances have been made in our ability to understand and treat osteosarcoma. In this article we describe the diagnosis, evaluation, and treatment of patients with this disease. The surgical issues are discussed. We review the major clinical trials that have led to our current level of understanding. The current studies for the treatment of osteosarcoma are described.
引用
收藏
页码:973 / +
页数:1
相关论文
共 93 条
[1]  
ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351
[2]   CHANGING PATTERN OF RELAPSE IN OSTEOSARCOMA OF THE EXTREMITIES TREATED WITH ADJUVANT AND NEOADJUVANT CHEMOTHERAPY [J].
BACCI, G ;
RUGGIERI, P ;
PICCI, P ;
BRICCOLI, A ;
FERRARO, A ;
FERRARI, S ;
TIENGHI, A ;
IANTORNO, D ;
CAMPANACCI, M .
JOURNAL OF CHEMOTHERAPY, 1995, 7 (03) :230-239
[3]  
BAUM ES, 1979, CANCER TREAT REP, V63, P1621
[4]  
BEATTIE EJ, 1975, CANCER, V35, P618, DOI 10.1002/1097-0142(197503)35:3<618::AID-CNCR2820350312>3.0.CO
[5]  
2-Z
[6]   THE RELATIONSHIP BETWEEN THALLIUM UPTAKE, BLOOD-FLOW, AND BLOOD POOL ACTIVITY IN BONE AND SOFT-TISSUE TUMORS [J].
CALUSER, C ;
MACAPINLAC, H ;
HEALEY, J ;
GHAVIMI, F ;
MEYERS, P ;
WOLLNER, N ;
KALAIGIAN, J ;
KOSTAKOGLU, L ;
ABDELDAYEM, HM ;
YEH, SDJ ;
LARSON, SM .
CLINICAL NUCLEAR MEDICINE, 1992, 17 (07) :565-572
[7]   ADJUVANT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA - THE TRIUMPH THAT ISNT [J].
CARTER, SK .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) :147-148
[8]   DOXORUBICIN IN DISSEMINATED OSTEOSARCOMA [J].
CORTES, EP ;
HOLLAND, JF ;
SINKS, LF ;
WANG, JJ .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 221 (10) :1132-&
[9]  
CORTES EP, 1978, CANCER TREAT REP, V62, P271
[10]   AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA [J].
CORTES, EP ;
HOLLAND, JF ;
WANG, JJ ;
SINKS, LF ;
BLOM, J ;
SENN, H ;
BANK, A ;
GLIDEWELL, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :998-1000